ClinicalTrials.Veeva

Menu

Dietary Peanuts and Nutrition-Related Outcomes

I

Ian J. Neeland, MD

Status

Not yet enrolling

Conditions

Food Acceptance
Obesity & Overweight
Dietary Change

Treatments

Procedure: Dual-energy X-ray absorptiometry (DEXA) scans
Dietary Supplement: Peanuts

Study type

Interventional

Funder types

Other

Identifiers

NCT07244458
STUDY20250426

Details and patient eligibility

About

This study will look at how eating peanuts every day might affect participants weight, how healthy their diet is, and how they feel when eating. Investigators want to see if adding peanuts to meals for 12 weeks helps participants feel fuller, have more energy, and improve body composition. The study will include adults who have been taking GLP-1 medicines like semaglutide or tirzepatide for at least three months. Investigators also want to see if eating peanuts improves overall diet quality and health markers like tiredness and certain levels in blood.

Enrollment

64 estimated patients

Sex

All

Ages

18 to 65 years old

Volunteers

Accepts Healthy Volunteers

Inclusion criteria

  • Individuals with a BMI ≥30 kg/m2 who intend to be continuously using semaglutide or tirzepatide for a clinical indication and remain on the therapy for at least 6 months

Exclusion criteria

  • No use or contraindication to use of a GLP-1 RA
  • Known allergy to nuts
  • Pregnant or breastfeeding
  • Incarcerated

Trial design

Primary purpose

Supportive Care

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

None (Open label)

64 participants in 2 patient groups

Peanut Group
Experimental group
Description:
Participants in this group will eat 2 ounces, or 53 grams of dry-roasted, lightly salted (low sodium) each day along with their regular diet.
Treatment:
Dietary Supplement: Peanuts
Procedure: Dual-energy X-ray absorptiometry (DEXA) scans
No Peanut Group
Active Comparator group
Description:
Participants in this group will continue eating regular diet without peanuts.
Treatment:
Procedure: Dual-energy X-ray absorptiometry (DEXA) scans

Trial contacts and locations

1

Loading...

Central trial contact

Ian Neeland, MD; Abigail Raffner, PhD, RD, LD

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems